PET放射性トレーサーの世界市場

PET放射性トレーサーの世界市場は2030年までに59億米ドルに達する

2024年に37億米ドルと推定されるPET放射性トレーサーの世界市場は、2024年から2030年にかけてCAGR 8.4%で成長し、2030年には59億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるF-18放射性トレーサーは、CAGR 9.6％を記録し、分析期間終了までに42億米ドルに達すると予測されています。Ga 68放射性トレーサーセグメントの成長率は、分析期間でCAGR 5.5％と推定されています。

米国市場は9億9,920万米ドルと推定、中国はCAGR13.2％で成長予測

米国のPET放射性トレーサー市場は、2024年に9億9,920万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.1%と8.0%と予測されています。欧州では、ドイツがCAGR 5.6%で成長すると予測されています。

世界のPET放射性トレーサー市場- 主要動向と促進要因のまとめ

現代の画像診断でPET放射性トレーサーが牽引役となっている理由とは？

陽電子放射断層撮影法（PET）放射性トレーサーは、特に腫瘍学、神経学、心臓病学において、高度な画像診断の基盤となるツールとなっています。これらの放射性医薬品は陽電子放出同位元素で標識された生物学的に活性な分子であり、臨床医は細胞レベルでの代謝や分子活動を可視化することができます。構造的な画像診断とは異なり、PET検査は疾患の進行、早期発見、治療効果に関する機能的な洞察を提供し、精密医療に不可欠なものとなっています。

世界のPET放射性トレーサー市場は、がん罹患率の増加、臨床応用の拡大、三次医療施設におけるPET-CTおよびPET-MRIハイブリッドシステムの統合により、力強い成長を遂げています。がん領域は依然として主要な応用領域であり、臨床用途では18F-FDG（フルオロデオキシグルコース）が最大のシェアを占めています。しかし、神経内分泌腫瘍用の68Ga-DOTATATEや前立腺がん再発用の18F-fluciclovineのような新規トレーサーは、診断の状況を急速に多様化しています。

さらに、サイクロトロン施設やラジオファーマシーネットワークなどの核医学インフラへの投資が増加し、PETトレーサーへの地域的なアクセスが向上しています。米国、欧州、アジア太平洋の規制機関は治験用放射性医薬品の承認プロセスを合理化し、臨床試験と商業的展開を加速しています。産学連携に支えられたこのエコシステムの成長が、従来のがん診断薬にとどまらない世界のPET放射性トレーサー市場を後押ししています。

技術の進歩は放射性トレーサーの開発と送達にどのような影響を与えているか？

PET用放射性トレーサーの技術革新は、同位体製造、放射化学の自動化、トレーサー特異的ターゲティング機構の進歩に大きく依存しています。サイクロトロンの小型化とジェネレーターベースのアイソトープシステム（例えば、68Ge/68Gaジェネレーター）の導入により、放射性トレーサーのオンサイトまたはオンサイトに近い生産が容易になり、従来の集中型サプライチェーンの半減期関連の制約が軽減されています。これは特に新興市場や遠隔地のヘルスケア施設でのアクセス拡大に役立っています。

現在、標的放射性トレーサーは受容体特異性を高めて設計されており、臨床医が腫瘍のサブタイプを区別し、分子レベルで治療効果をモニターできるようになっています。例えば、18F-FESは乳がんのエストロゲン受容体をターゲットとし、PSMAリガンドに基づくトレーサーは前立腺がんの診断とセラノスティックスを再構築しています。神経学では、18F-florbetapirと18F-fortaucipirがアルツハイマー病におけるアミロイドとタウの病態を画像化するために使用され、早期の認知機能低下診断をサポートしています。

カセットベースの合成モジュールやマイクロ流体チップのような放射性トレーサー合成の自動化プラットフォームは、人的ミスを減らし、純度を高め、生産時間を早めています。また、放射性医薬品メーカーは、手順を標準化し、医療スタッフの放射線被ばくリスクを低減するために、コールドキットやすぐに使える注射剤の開発にも取り組んでいます。放射性医薬品が疾患固有の診断ニーズに対応できるように進化するにつれ、テクノロジーは拡張性、効率性、安全性を実現する重要な要素となっています。

市場拡大を牽引する臨床アプリケーションと地域は？

腫瘍学がPET放射性トレーサーの中核市場である一方、神経学と循環器学の新しい適応症が牽引役となっています。アルツハイマー病診断では、アミロイドやタウPETイメージングの採用が増加し、疾患修飾療法の承認に支えられて、新たな成長経路が生まれつつあります。同様に、13N-アンモニアや82Rbなどの灌流トレーサーを用いた心臓PETイメージングも、複雑な冠動脈疾患を持つ患者の心筋生存能や虚血の評価に役立っています。

地理的には、北米は強力な放射性医薬品製造基盤があり、一人当たりのヘルスケア支出が高く、高度なイメージングセンターが存在するため、依然として支配的な市場です。米国FDAはDrug Master File制度やRadioactive Drug Research Committee（RDRC）の枠組みのようなイニシアチブの下で放射性トレーサー開発を支援しており、技術革新を促進しています。ドイツ、英国、フランスは核医学部門が確立され、PET-MRI設備が増加しているため、導入曲線をリードしています。

アジア太平洋は最も急成長している地域であり、日本、中国、韓国のような国々が国内のアイソトープ生産に投資し、PETイメージングインフラを拡大しています。インドでは、特に3次がんセンターでのPETトレーサー開発のための官民パートナーシップが増加しています。ラテンアメリカと中東の一部では、インフラ格差と高い調達コストによって制限されているもの、導入の初期兆候が見られます。

PET放射性トレーサー世界市場の成長を牽引しているのは？

世界のPET放射性トレーサー市場の成長を牽引しているのは、がんや神経変性疾患の罹患率の上昇、ハイブリッド画像診断モダリティの採用拡大、核医学インフラの急速な拡大、疾患を標的としたトレーサー設計の継続的な革新です。精密診断が現代のヘルスケアの中心になるにつれ、早期かつ正確で実用的な知見を提供する放射線トレーサーの需要が急増しています。

主な成長促進要因としては、放射性医薬品研究開発に対する政府の支援、規制枠組みの合理化、放射化学自動化の進歩などが挙げられます。価値観に基づく医療と個別化医療への臨床シフトは、診断の曖昧さを減らし治療成果を向上させる分子イメージングツールの採用を病院に促しています。民間企業は、拡大する放射性トレーサーのパイプライン、強固な供給ネットワーク、標的治療用のコンパニオン診断薬で対応しています。

さらに、教育イニシアティブと核医学トレーニングプログラムは、世界の放射性薬剤師の人材プールを強化し、安全でコンプライアントなトレーサーの取り扱いを保証するのに役立っています。需要が臨床の専門分野や地域によって多様化し続ける中、PET放射性トレーサー市場は急速に拡大し、次世代医療イメージングの要としての役割を確立する好位置にあります。

セグメント

放射性トレーサー（F-18放射性トレーサー、Ga 68放射性トレーサー、その他の放射性トレーサータイプ）;アプリケーション（がん、心臓病、消化器、内分泌、神経疾患、その他）;エンドユーザー（病院、診断センター、その他）

調査対象企業の例

• ABX Advanced Biochemical Compounds GmbH
• Advanced Accelerator Applications
• AstraZeneca PLC
• Avid Radiopharmaceuticals
• Blue Earth Diagnostics
• Cardinal Health Inc.
• Eli Lilly and Company
• GE HealthCare
• IBA Radiopharma Solutions S.A.
• ImaginAb Inc.
• IXICO PLC
• Jubilant Pharma Limited
• Lantheus Holdings Inc.
• Neusoft Medical Systems Co. Ltd.
• Nordion Inc.
• Positron Corporation
• Radiomedix Inc.
• Siemens Healthineers AG
• SOFIE Biosciences Inc.
• Yantai Dongcheng Pharmaceutical

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global PET Radiotracers Market to Reach US$5.9 Billion by 2030

The global market for PET Radiotracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. F-18 Radiotracer, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Ga 68 Radiotracer segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$999.2 Million While China is Forecast to Grow at 13.2% CAGR

The PET Radiotracers market in the U.S. is estimated at US$999.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global PET Radiotracers Market - Key Trends & Drivers Summarized

Why Are PET Radiotracers Gaining Traction in Modern Diagnostic Imaging?

Positron Emission Tomography (PET) radiotracers have become foundational tools in advanced diagnostic imaging, particularly in oncology, neurology, and cardiology. These radiopharmaceuticals, which are biologically active molecules labeled with positron-emitting isotopes, enable clinicians to visualize metabolic and molecular activity at a cellular level. Unlike structural imaging modalities, PET scans offer functional insights into disease progression, early detection, and treatment response, making them indispensable in precision medicine.

The global PET radiotracers market is experiencing robust growth due to increasing cancer prevalence, expanding clinical applications, and the integration of PET-CT and PET-MRI hybrid systems in tertiary healthcare facilities. Oncology remains the dominant application area, with 18F-FDG (fluorodeoxyglucose) accounting for the largest share of clinical usage. However, novel tracers like 68Ga-DOTATATE for neuroendocrine tumors and 18F-fluciclovine for prostate cancer recurrence are rapidly diversifying the diagnostic landscape.

Furthermore, rising investments in nuclear medicine infrastructure-such as cyclotron facilities and radiopharmacy networks-are improving regional accessibility to PET tracers. Regulatory bodies in the U.S., Europe, and Asia-Pacific have streamlined the approval process for investigational radiopharmaceuticals, accelerating clinical trials and commercial deployment. This growing ecosystem, supported by academic-industry collaboration, is propelling the global PET radiotracers market beyond conventional cancer diagnostics.

How Are Technological Advancements Influencing Radiotracer Development and Delivery?

PET radiotracer innovation is heavily reliant on advances in isotope production, radiochemistry automation, and tracer-specific targeting mechanisms. The miniaturization of cyclotrons and the deployment of generator-based isotope systems (e.g., 68Ge/68Ga generators) are facilitating onsite or near-site production of radiotracers, reducing the half-life-related limitations of traditional centralized supply chains. This has especially helped expand access in emerging markets and remote healthcare facilities.

Targeted radiotracers are now being designed with increased receptor specificity, allowing clinicians to differentiate between tumor subtypes and monitor treatment efficacy at the molecular level. For example, 18F-FES targets estrogen receptors in breast cancer, while PSMA-ligand-based tracers are reshaping prostate cancer diagnostics and theranostics. In neurology, 18F-florbetapir and 18F-flortaucipir are being used to image amyloid and tau pathology in Alzheimer's disease, supporting early-stage cognitive decline diagnostics.

Automation platforms for radiotracer synthesis, such as cassette-based synthesis modules and microfluidic chips, are reducing human error, enhancing purity, and accelerating production times. Radiopharmaceutical manufacturers are also working on cold kits and ready-to-use injectables to standardize procedures and reduce radiation exposure risks for medical staff. As radiotracers evolve to meet disease-specific diagnostic needs, technology is acting as the critical enabler of scalability, efficiency, and safety.

Which Clinical Applications and Geographic Regions Are Driving Market Expansion?

While oncology represents the core market for PET radiotracers, newer indications in neurology and cardiology are gaining traction. In Alzheimer's diagnostics, increased adoption of amyloid and tau PET imaging-supported by the approval of disease-modifying therapies-is creating new growth pathways. Similarly, cardiac PET imaging using perfusion tracers like 13N-ammonia and 82Rb is helping evaluate myocardial viability and ischemia in patients with complex coronary artery disease.

Geographically, North America remains the dominant market due to its strong radiopharmaceutical manufacturing base, high per capita healthcare spending, and the presence of advanced imaging centers. The U.S. FDA's support for radiotracer development under initiatives like the Drug Master File system and the Radioactive Drug Research Committee (RDRC) framework is expediting innovation. Europe is closely following, with Germany, the UK, and France leading the adoption curve due to well-established nuclear medicine departments and growing PET-MRI installations.

Asia-Pacific is emerging as the fastest-growing region, with countries like Japan, China, and South Korea investing in domestic isotope production and expanding their PET imaging infrastructure. India is witnessing increased public-private partnerships for PET tracer development, particularly in tertiary cancer centers. Latin America and parts of the Middle East are showing early signs of adoption, albeit limited by infrastructure gaps and high procurement costs.

What Is Driving Growth in the Global PET Radiotracers Market?

The growth in the global PET radiotracers market is driven by the rising incidence of cancer and neurodegenerative disorders, increasing adoption of hybrid imaging modalities, rapid expansion of nuclear medicine infrastructure, and continued innovation in disease-targeted tracer design. As precision diagnostics become central to modern healthcare, demand for radiotracers that provide early, accurate, and actionable insights is rising sharply.

Key growth drivers include government support for radiopharmaceutical R&D, streamlined regulatory frameworks, and advancements in radiochemistry automation. The clinical shift toward value-based care and personalized medicine is prompting hospitals to adopt molecular imaging tools that can reduce diagnostic ambiguity and improve therapeutic outcomes. Commercial players are responding with an expanding pipeline of radiotracers, robust supply networks, and companion diagnostics for targeted therapies.

Moreover, educational initiatives and nuclear medicine training programs are strengthening the global radiopharmacist talent pool, helping ensure safe and compliant tracer handling. As demand continues to diversify across clinical specialties and geographies, the PET radiotracers market is well-positioned to scale rapidly, anchoring its role as a cornerstone of next-generation medical imaging.

SCOPE OF STUDY:

The report analyzes the PET Radiotracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiotracer (F-18 Radiotracer, Ga 68 Radiotracer, Other Radiotracer Types); Application (Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application, Other Applications); End-User (Hospitals End-User, Diagnostic Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• ABX Advanced Biochemical Compounds GmbH
• Advanced Accelerator Applications
• AstraZeneca PLC
• Avid Radiopharmaceuticals
• Blue Earth Diagnostics
• Cardinal Health Inc.
• Eli Lilly and Company
• GE HealthCare
• IBA Radiopharma Solutions S.A.
• ImaginAb Inc.
• IXICO PLC
• Jubilant Pharma Limited
• Lantheus Holdings Inc.
• Neusoft Medical Systems Co. Ltd.
• Nordion Inc.
• Positron Corporation
• Radiomedix Inc.
• Siemens Healthineers AG
• SOFIE Biosciences Inc.
• Yantai Dongcheng Pharmaceutical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • PET Radiotracers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Precision Oncology Throws the Spotlight on PET-Based Molecular Imaging Agents
  • Growth in Cancer Screening and Early Detection Programs Spurs Radiotracer Utilization
  • Expansion of Theranostics and Targeted Therapy Monitoring Drives Development of New PET Radiotracers
  • FDA Approvals of Novel PET Tracers for PSMA and Amyloid Imaging Accelerate Market Expansion
  • Increased Use of PET/CT and PET/MRI Hybrids Strengthens Business Case for Multi-Organ Tracers
  • Shift Toward Personalized Medicine Supports Companion Diagnostic Applications of Radiotracers
  • Technological Advancements in Cyclotron and Radiopharmacy Infrastructure Enhance Supply Efficiency
  • Emergence of AI in Image Interpretation Propels Integration with Biomarker-Specific Tracers
  • Surge in Neurology Imaging Drives Demand for PET Tracers in Alzheimer's and Parkinson's Diagnostics
  • Increased PET Application in Cardiovascular Imaging Expands Beyond Oncology Use Cases
  • R&D in Fluorine-18 and Gallium-68 Radiochemistry Fuels Development of Novel Agents
  • Strategic Collaborations Between Pharma and Imaging Providers Drive Companion Tracer Commercialization
  • Regulatory Streamlining of Investigational New Drug (IND) Applications Supports Faster Innovation Cycles
  • Limited Half-Life and Logistics of Short-Lived Isotopes Spur Investment in Decentralized Production
  • Growth in PET-Guided Biopsies and Therapeutic Planning Enhances Clinical Utility of Tracers
  • Clinical Trial Activity in Targeted Immunotherapies Spurs Use of Novel Radioligands
  • Rising Investments in Academic Radiochemistry Programs Expands Pipeline of First-in-Class Tracers
  • PET Radiotracer Market Expansion in Asia-Pacific Driven by Diagnostic Infrastructure Growth
  • Shift Toward Outpatient Imaging and Mobile PET Units Sustains Demand for On-Site Radiotracer Solutions
  • Increased Demand for Theranostic Pairings with Radiopharmaceutical Therapeutics Spurs Innovation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World PET Radiotracers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for F-18 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Ga 68 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Radiotracer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Diagnostic Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Gastrointestinal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Endocrine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Neurological Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION